Company Intelligence Profile
Tata 1Mg Healthcare Solutions Private Limited
Tata 1mg's pharmaceutical trading/distribution entity — part of the Tata Digital-owned "Tata 1mg" online pharmacy and digital healthcare platform.
CIN: U24290DL2016PTC302634ActiveRoC-DelhiConfidence: medium
Last updated 6 September 2026
AI OverviewGenerated from public records
AI-generated summary from public filings and may contain errors. Verify against the detailed sections below.
Unlock the full profile on AICA
Deeper analysis, financial signals and peer comparisons.
Company Identity
Partial / conflicting| Registered name | Tata 1Mg Healthcare Solutions Private Limited |
|---|---|
| CIN | U24290DL2016PTC302634 |
| PAN | AAFCD7691C |
| Status | Active (Private Limited, non-government company) |
| Listing | Not listed (unlisted private limited company; ultimate parent Tata Sons group is diversified, not itself listed for this entity) |
| Incorporated | 06 July 2016 |
| ROC | RoC-Delhi |
| Sector (NIC) |
|
| Registered address | 2nd Floor, Plot No. B-225, Okhla Industrial Area, Phase-I, New Delhi, Delhi 110020 |
| Authorized capital | ₹1,538.76 Crore |
| Paid-up capital | ₹834.37 Crore |
Business Overview
Partial / conflicting- Tata 1mg Healthcare Solutions Private Limited is part of the "Tata 1mg" integrated healthcare platform (majority-owned by Tata Digital Private Limited since the 2021 acquisition of the original 1mg business)
- Per Tofler's registry description, this entity's core activity is trading/distribution of generic drugs and pharmaceutical products (capsules, syrups, suspensions, drops, tablets, injections, dry syrup, ointments, protein powders)
- Commercially, "Tata 1mg" operates as India's e-pharmacy and digital healthcare ecosystem offering online medicine ordering with home delivery, lab/diagnostic testing with home sample collection, teleconsultations, health devices, vaccination-at-home, and subscription health plans
- Note: it is not fully certain whether all consumer-facing platform operations (app/tech) sit inside this exact CIN vs. a sibling/parent entity — see financials note below
Directors
Partial / conflicting| Name | DIN | Role | Appointed |
|---|---|---|---|
| Tanmay Saksena | 03623581 | Director | 01 Nov 2017 |
| Gaurav Agarwal | 07497713 | - | - |
| Nikhil Doegar | 10175087 | - | - |
Financials
Partial / conflicting- FY2024-25 (year ended 31 Mar 2025), standalone, per Tofler/TheCompanyCheck registry filings: Revenue ≈ ₹2,019.69 Cr / ₹2,000-2,250 Cr range, up ~17% YoY. Tofler ratios (Mar-2025): Gross margin 0.96%, Operating margin 2.41%, Net profit margin 2.67% (implies a small positive net profit, roughly ₹50-55 Cr, on a standalone basis), ROCE -62.23%, Debt-to-equity 0.08, borrowings up 28.04% YoY, assets up 35.37% YoY. EBITDA and absolute PAT/net-worth figures were paywalled and not obtained
- IMPORTANT ENTITY-CONFUSION CAUTION: press coverage widely reports large losses for "Tata 1mg" — FY22 loss ₹526 Cr, FY23 loss ₹1,259 Cr, FY24 loss ₹313 Cr — but these figures are inconsistent with the small POSITIVE net margin shown by the registry filing for this exact CIN (Tata 1Mg Healthcare Solutions Private Limited) in FY25
- This strongly suggests the widely-reported loss figures belong to a different group entity (likely "1MG Technologies Private Limited," the original/consolidated 1mg entity or holding company) rather than to this specific subsidiary CIN
- The loss figures are NOT attributed to this entity in this profile to avoid the entity-confusion trap; they are noted only as a caution for the SEO page author
Funding
Partial / conflicting- Not directly attributable to this exact CIN with confidence — funding/M&A activity is documented for the broader "1mg"/"Tata 1mg" business, not confirmed as booked into this specific subsidiary
- Per Inc42: Tata Digital Private Limited (Tata Sons' digital arm) acquired a majority stake in 1mg in June 2021
- A further $40 Mn round led by Tata Digital was reported in September 2022, after which "Tata 1mg" was described in press as having crossed unicorn ($1Bn+) valuation
- Use Tracxn only for round-name/date corroboration if needed; not independently re-verified here
In the News
ConfirmedTata 1mg revenue nears Rs 3,000 Cr in FY26; loss narrows to Rs 287 Cr
Entrackr · a month ago
Tata 1mg FY26 Revenue Grows 23 Pc to Rs 2,936 Cr
Indian Retailer · a month ago
Tata 1mg narrows losses in core healthcare business
Livemint · a month ago
Headlines about Tata 1Mg Healthcare Solutions Private Limited reported by third-party publications. Recur Club does not author or endorse this coverage. Last checked 14 days ago.
Source: Google News aggregated headlines
Charges & Loans
Partial / conflicting- Conflicting data between two sources — flagged, not resolved in this pass: (a) TheCompanyCheck states 0 open charges and ₹88.1 Cr in satisfied charges across six charge instances (ranging ₹5-40 Cr each, dated 2018-2021, lender type listed only as "Others," lender names not disclosed)
- (b) Tofler's charges page states "the company has no registered charges" at all
- Given the conflict, charge history should be treated as partial/unconfirmed pending a primary MCA filing check
Legal / Litigation
Confirmed- Confirmed (Indian Kanoon, Delhi High Court orders — entity named directly in each case, so reliably attributable to this company): (1) Qrg Medicare Private Limited vs Tata 1Mg Healthcare Solutions Private Limited — Delhi HC, order dated 01 Aug 2025 (Justice Purushaindra Kumar Kaurav)
- (2) Tata 1Mg Healthcare Solutions Private Limited vs Ritu Dua (Proprietor, Shree Aditya) — Delhi HC, O.M.P.(MISC.)(COMM.) 504/2023, order dated 11 Oct 2023 (Justice Sachin Datta)
- (3) Tata 1Mg Healthcare Solutions Private Limited vs Marengo Asia Healthcare Private Limited — Delhi HC, ARB.P
- 1118/2025 & I.A. 18383/2025, order dated 31 Jul 2025
- (4) North East Healthcare Private Limited vs Tata 1Mg Healthcare Solutions Private Limited — Delhi HC, order dated 07 Aug 2025
- (5) Marengo Asia Healthcare Private Limited vs Tata 1Mg Healthcare Solutions Private Limited — Delhi HC, order dated 07 Aug 2025
- (6) Qrg Medicare Private Limited vs Tata 1Mg Healthcare Solutions Private Limited — Delhi HC, order dated 07 Aug 2025
- Mostly commercial/arbitration matters; no criminal or regulatory-penalty orders surfaced
- (Separately, press has reported DCGI regulatory notices to e-pharmacies including Tata 1mg in Feb 2023 — not independently verified via a legal filing in this pass, noted as context only.)
Competitors
ConfirmedPharmEasy
large-scale e-pharmacy/diagnostics peer, comparable/larger scale historically
Netmeds
large-scale e-pharmacy peer
Apollo 24|7
large integrated healthcare peer
MedPlus Mart / Medlife
large pharmacy retail chain + e-pharmacy
Truemeds
mid-scale generics-focused e-pharmacy, smaller scale
Practo
mid-scale, telemedicine/doctor-discovery focused rather than pharmacy-first
Frequently Asked Questions
What does Tata 1Mg Healthcare Solutions Private Limited do?
Tata 1mg's pharmaceutical trading/distribution entity — part of the Tata Digital-owned "Tata 1mg" online pharmacy and digital healthcare platform.
What is the CIN of Tata 1Mg Healthcare Solutions Private Limited?
The Corporate Identification Number (CIN) of Tata 1Mg Healthcare Solutions Private Limited is U24290DL2016PTC302634.
Where is Tata 1Mg Healthcare Solutions Private Limited registered?
Tata 1Mg Healthcare Solutions Private Limited is registered with RoC-Delhi (confirmed — Tofler, TheCompanyCheck). Registered address: 2nd Floor, Plot No. B-225, Okhla Industrial Area, Phase-I, New Delhi, Delhi 110020 (confirmed — Tofler, TheCompanyCheck, Falconebiz)
When was Tata 1Mg Healthcare Solutions Private Limited incorporated?
Tata 1Mg Healthcare Solutions Private Limited was incorporated on 06 July 2016 (confirmed — Tofler, TheCompanyCheck).
Explore on Recur Club
Revenue-Based FinancingRepay as a share of monthly revenueWorking Capital LoansCollateral-light capital for operationsSecured Term LoansLarger, longer-tenure debtCheck Your EligibilityEstimate funding in minutesCompany SearchExplore more company profilesFinance CalculatorsFree tools for founders & finance teams
Bharat Ke Super Founders
Recur Club's show spotlighting the founders building India's next generation of companies. Watch their stories.
Looking for business funding?
Recur Club is India's largest AI-native debt platform - working capital, term loans and structured debt from 150+ lending partners, without diluting equity.